{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:04:08Z","timestamp":1792047848125,"version":"4.4.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Activation of coagulation factor (F) XI promotes multiorgan failure in rodent models of sepsis and in a baboon model of lethal systemic inflammation induced by infusion of heat-inactivated Staphylococcus aureus. Here we used the anticoagulant FXII-neutralizing antibody 5C12 to verify the mechanistic role of FXII in this baboon model. Compared with untreated control animals, repeated 5C12 administration before and at 8 and 24 hours after bacterial challenge prevented the dramatic increase in circulating complexes of contact system enzymes FXIIa, FXIa, and kallikrein with antithrombin or C1 inhibitor, and prevented cleavage and consumption of high-molecular-weight kininogen. Activation of several coagulation factors and fibrinolytic enzymes was also prevented. D-dimer levels exhibited a profound increase in the untreated animals but not in the treated animals. The antibody also blocked the increase in plasma biomarkers of inflammation and cell damage, including tumor necrosis factor, interleukin (IL)-1\u03b2, IL-6, IL-8, IL-10, granulocyte-macrophage colony-stimulating factor, nucleosomes, and myeloperoxidase. Based on clinical presentation and circulating biomarkers, inhibition of FXII prevented fever, terminal hypotension, respiratory distress, and multiorgan failure. All animals receiving 5C12 had milder and transient clinical symptoms and were asymptomatic at day 7, whereas untreated control animals suffered irreversible multiorgan failure and had to be euthanized within 2 days after the bacterial challenge. This study confirms and extends our previous finding that at least 2 enzymes of the contact activation complex, FXIa and FXIIa, play critical roles in the development of an acute and terminal inflammatory response in baboons challenged with heat-inactivated S aureus.<\/jats:p>","DOI":"10.1182\/blood.2020009345","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T20:27:05Z","timestamp":1613852825000},"page":"178-189","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":33,"title":["Factor XII plays a pathogenic role in organ failure and death in baboons challenged with<i>Staphylococcus aureus<\/i>"],"prefix":"10.1182","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9590-6160","authenticated-orcid":false,"given":"Robert","family":"Silasi","sequence":"first","affiliation":[{"name":"Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4177-9095","authenticated-orcid":false,"given":"Ravi S.","family":"Keshari","sequence":"additional","affiliation":[{"name":"Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-3783","authenticated-orcid":false,"given":"Girija","family":"Regmi","sequence":"additional","affiliation":[{"name":"Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-0893","authenticated-orcid":false,"given":"Cristina","family":"Lupu","sequence":"additional","affiliation":[{"name":"Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Georgescu","sequence":"additional","affiliation":[{"name":"Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1815-6831","authenticated-orcid":false,"given":"Joe H.","family":"Simmons","sequence":"additional","affiliation":[{"name":"Michale E. Keeling Center for Comparative Medicine and Research, University of Texas MD Anderson Cancer Center, Bastrop, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7133-795X","authenticated-orcid":false,"given":"Michael","family":"Wallisch","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR;"},{"name":"Aronora, Inc, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-0016","authenticated-orcid":false,"given":"Tia C. L.","family":"Kohs","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Shatzel","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR;"},{"name":"Division of Hematology & Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2717-4620","authenticated-orcid":false,"given":"Sven R.","family":"Olson","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR;"},{"name":"Division of Hematology & Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-2352","authenticated-orcid":false,"given":"Christina U.","family":"Lorentz","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR;"},{"name":"Aronora, Inc, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5911-8156","authenticated-orcid":false,"given":"Cristina","family":"Puy","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik I.","family":"Tucker","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR;"},{"name":"Aronora, Inc, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-8014","authenticated-orcid":false,"given":"David","family":"Gailani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3072-9244","authenticated-orcid":false,"given":"Sidney","family":"Strickland","sequence":"additional","affiliation":[{"name":"Patricia and John Rosenwald Laboratory of Neurobiology and Genetics, The Rockefeller University, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-2247","authenticated-orcid":false,"given":"Andr\u00e1s","family":"Gruber","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR;"},{"name":"Aronora, Inc, Portland, OR;"},{"name":"Division of Hematology & Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen J. T.","family":"McCarty","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR;"},{"name":"Division of Hematology & Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1249-9278","authenticated-orcid":false,"given":"Florea","family":"Lupu","sequence":"additional","affiliation":[{"name":"Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK;"},{"name":"Department of Cell Biology,"},{"name":"Department of Pathology, and"},{"name":"Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"issue":"10219","key":"2021071515240279700_B1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"2021071515240279700_B2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.mcna.2020.02.011","article-title":"Sepsis and septic shock\u2014basics of diagnosis, pathophysiology and clinical decision making","volume":"104","author":"Font","year":"2020","journal-title":"Med Clin North Am"},{"issue":"22","key":"2021071515240279700_B3","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2021071515240279700_B4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/509899","article-title":"Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III","volume":"79","author":"Cichon","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2021071515240279700_B5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1172\/JCI116201","article-title":"The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons","volume":"91","author":"Pixley","year":"1993","journal-title":"J Clin Invest"},{"issue":"4","key":"2021071515240279700_B6","first-page":"897","article-title":"Activation of the contact system in lethal hypotensive bacteremia in a baboon model","volume":"140","author":"Pixley","year":"1992","journal-title":"Am J Pathol"},{"issue":"6","key":"2021071515240279700_B7","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.V87.6.2337.bloodjournal8762337","article-title":"Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase","volume":"87","author":"Jansen","year":"1996","journal-title":"Blood"},{"issue":"2","key":"2021071515240279700_B8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1086\/589514","article-title":"Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis","volume":"198","author":"Tucker","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"2021071515240279700_B9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1128\/IAI.05568-11","article-title":"Factor XI-deficient mice display reduced inflammation, coagulopathy, and bacterial growth during listeriosis","volume":"80","author":"Luo","year":"2012","journal-title":"Infect Immun"},{"issue":"20","key":"2021071515240279700_B10","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood-2011-10-386185","article-title":"Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis","volume":"119","author":"Tucker","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2021071515240279700_B11","doi-asserted-by":"crossref","first-page":"e0152968","DOI":"10.1371\/journal.pone.0152968","article-title":"Factor XI deficiency alters the cytokine response and activation of contact proteases during polymicrobial sepsis in mice","volume":"11","author":"Bane","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"2021071515240279700_B12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/bloodadvances.2018029983","article-title":"Inhibition of contact-mediated activation of factor XI protects baboons against S aureus-induced organ damage and death [published correction appears in Blood Adv. 2020;4(15):3741]","volume":"3","author":"Silasi","year":"2019","journal-title":"Blood Adv"},{"issue":"8","key":"2021071515240279700_B13","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/ATVBAHA.118.311193","article-title":"Factor XII activation promotes platelet consumption in the presence of bacterial-type long-chain polyphosphate in vitro and in vivo","volume":"38","author":"Zilberman-Rudenko","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2021071515240279700_B14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/SHK.0000000000000397","article-title":"Comparison of the proinflammatory and procoagulant properties of nuclear, mitochondrial, and bacterial DNA","volume":"44","author":"Bhagirath","year":"2015","journal-title":"Shock"},{"issue":"8","key":"2021071515240279700_B15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2017-10-813618","article-title":"Peptidoglycan induces disseminated intravascular coagulation in baboons through activation of both coagulation pathways","volume":"132","author":"Popescu","year":"2018","journal-title":"Blood"},{"issue":"11","key":"2021071515240279700_B16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","article-title":"Factor XII inhibition reduces thrombus formation in a primate thrombosis model","volume":"123","author":"Matafonov","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2021071515240279700_B17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/rth2.12309","article-title":"Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates","volume":"4","author":"Wallisch","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"2021071515240279700_B18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.dadm.2018.06.008","article-title":"A novel detection method of cleaved plasma high-molecular-weight kininogen reveals its correlation with Alzheimer\u2019s pathology and cognitive impairment","volume":"10","author":"Yamamoto-Imoto","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"issue":"31","key":"2021071515240279700_B19","doi-asserted-by":"crossref","first-page":"E6390","DOI":"10.1073\/pnas.1706818114","article-title":"Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis","volume":"114","author":"Keshari","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021071515240279700_B20","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-2873-3","volume-title":"Transformation and Weighting in Regression","author":"Carroll","year":"1988","edition":"1st ed"},{"key":"2021071515240279700_B21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","article-title":"An analysis of transformations","volume":"26","author":"Box","year":"1964","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"516","key":"2021071515240279700_B22","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/01621459.2016.1180986","article-title":"Smoothing parameter and model selection for general smooth models","volume":"111","author":"Wood","year":"2016","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"2021071515240279700_B23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rth2.12217","article-title":"The contact pathway and sepsis","volume":"3","author":"Raghunathan","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"2021071515240279700_B24","doi-asserted-by":"crossref","first-page":"E728","DOI":"10.3390\/jcm8050728","article-title":"Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"8","author":"Iba","year":"2019","journal-title":"J Clin Med"},{"issue":"2","key":"2021071515240279700_B25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/jccm-2017-0011","article-title":"Anticoagulant therapy in sepsis. The importance of timing","volume":"3","author":"Scarlatescu","year":"2017","journal-title":"J Crit Care Med (Targu Mures)"},{"issue":"4","key":"2021071515240279700_B26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/rth2.12235","article-title":"Factor XII\u2014what\u2019s important but not commonly thought about","volume":"3","author":"Schmaier","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"2021071515240279700_B27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1647467","article-title":"Thromboembolism and bleeding tendency in congenital factor XII deficiency\u2014a study on 74 subjects from 14 Swiss families","volume":"65","author":"L\u00e4mmle","year":"1991","journal-title":"Thromb Haemost"},{"key":"2021071515240279700_B28","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3389\/fimmu.2019.02011","article-title":"Roles of factor XII in innate immunity","volume":"10","author":"Renn\u00e9","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"2021071515240279700_B29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","article-title":"Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis","volume":"125","author":"Stavrou","year":"2010","journal-title":"Thromb Res"},{"issue":"11 pt B","key":"2021071515240279700_B30","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.bbamcr.2017.07.009","article-title":"The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity","volume":"1864","author":"Weidmann","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"2","key":"2021071515240279700_B31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000484257","article-title":"Kallikrein cleaves C3 and activates complement","volume":"10","author":"Irmscher","year":"2018","journal-title":"J Innate Immun"},{"issue":"222","key":"2021071515240279700_B32","doi-asserted-by":"crossref","first-page":"222ra17","DOI":"10.1126\/scitranslmed.3006804","article-title":"A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk","volume":"6","author":"Larsson","year":"2014","journal-title":"Sci Transl Med"},{"key":"2021071515240279700_B33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/asheducation-2017.1.674","article-title":"Anticoagulation with VADs and ECMO: walking the tightrope","volume":"2017","author":"Raffini","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"2021071515240279700_B34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0037-1603937","article-title":"Inhibition of factors XI and XII for prevention of thrombosis induced by artificial surfaces","volume":"44","author":"Tillman","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2021071515240279700_B35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.ATV.15.5.612","article-title":"Transcriptional regulation of tissue factor expression in human endothelial cells","volume":"15","author":"Parry","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2021071515240279700_B36","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/01.ATV.17.8.1550","article-title":"Intracellular calcium mobilization suppresses the TNF-alpha-stimulated synthesis of PAI-1 in human endothelial cells. Indications that calcium acts at a translational level","volume":"17","author":"Peiretti","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2021071515240279700_B37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00024382-200013020-00003","article-title":"Peritonitis in the baboon: a primate model which stimulates human sepsis","volume":"13","author":"Kinasewitz","year":"2000","journal-title":"Shock"},{"issue":"3","key":"2021071515240279700_B38","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1172\/JCI92880","article-title":"Factor XII and uPAR upregulate neutrophil functions to influence wound healing","volume":"128","author":"Stavrou","year":"2018","journal-title":"J Clin Invest"},{"issue":"3","key":"2021071515240279700_B39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/jth.13928","article-title":"Staphylococcus aureus, master manipulator of the human hemostatic system","volume":"16","author":"Liesenborghs","year":"2018","journal-title":"J Thromb Haemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/138\/2\/178\/1814063\/bloodbld2020009345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/138\/2\/178\/1814063\/bloodbld2020009345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T15:20:55Z","timestamp":1724512855000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/138\/2\/178\/475245\/Factor-XII-plays-a-pathogenic-role-in-organ"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,17]]},"published-print":{"date-parts":[[2021,7,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020009345","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]}}}